top of page

State-by-state scorecard reveals wide gaps in access to obesity treatments in the US

12 minutes ago
3 min read

Where Americans live can make a profound difference in their ability to access obesity treatment, according to a new state-by-state scorecard and report that gives 20 states D or F grades and finds significant barriers to care in every state in the US. With states averaging a C− and only one earning an A-, the report reveals major differences in insurance coverage, treatment restrictions and utilisation, available specialists and facilities, leaving millions of Americans struggling to receive treatment even as obesity rates remain high across the country.


Developed by the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Obesity Action Coalition (OAC), the Obesity Treatment Access Scorecard, ranks each of the 50 states and the District of Columbia for their residents’ ability to access comprehensive obesity care, including nutrition counselling, behavioural interventions, FDA-approved medications, endoscopic therapies, metabolic and bariatric surgery, and long-term follow-up care. Researchers made assessments based on 44 metrics of access.


Minnesota emerged as the best state in the nation for obesity access with a score of 76.4 out of 100 (A−), followed by New York (71.6, B+), Massachusetts (71.5, B+), Delaware (70.6, B+) and Rhode Island (67.9, B). Among the five worst were South Carolina (30.9, D), Idaho (30.2, D-), West Virginia (28.9, F), Oklahoma (28.5, F) and Arkansas (25.5, F). Several big states also performed poorly or received middling grades, including Texas (39.0, D), Florida (40.6, D+), California (49.8, C−) and Pennsylvania (49.0, C−).

The results suggest a troubling overlap between high obesity prevalence and poor access to care. West Virginia and Oklahoma, both graded F, are among the states with the highest adult obesity rates and the poorest access though the study was not designed to determine a causal link.

CDC puts obesity prevalence at roughly four in ten adults in these states, raising concerns that people in places with significant needs may face some of the biggest obstacles to obtaining care. Conversely, high obesity rates do not necessarily correspond to poor treatment access. Minnesota, ranked first in the nation for access with an A− grade, still has an adult obesity rate of about 33%.


"Coverage alone does not guarantee access or treatment. Many other barriers interfere with patients’ ability to receive care, from prior authorization requirements and treatment exclusions to shortages of qualified specialists, high out-of-pocket costs and long distances to comprehensive treatment centres and physicians. All can delay or prevent people from receiving treatments that could significantly improve their health and quality of life and it’s playing out in every state in America,” said Dr John Scott, Vice President of the ASMBS.


Access to newer obesity medications is also becoming increasingly uncertain. According to the report, seven state Medicaid programs ended or planned to end coverage of GLP-1 medications used to treat obesity in 2026, potentially disrupting treatment for a chronic disease. Private insurers and employers are also increasingly dropping coverage and without insurance, the cost of the drugs is prohibitively high for many patients.


Metabolic and bariatric surgery remains one of the most underutilised treatments in medicine with a yearly utilization rate of about 1% due to restrictions on eligibility, physician referral patterns, misperceptions on safety and effectiveness, treatment bias, and challenges receiving long-term care post-surgery.


"Your ZIP code should not determine whether you can get proven treatments for obesity, yet the scorecard shows that where you live does make a real difference,” said Joseph Nadglowski, President and CEO of the Obesity Action Coalition. " People deserve access to the full range of evidence-based treatments without unnecessary barriers, discrimination or stigma. This scorecard is meant to give policymakers, insurers, employers, healthcare professionals and advocates a way to identify and understand barriers and peruse state-specific solutions.”


Scorecard findings

The scorecard groups its 44 measures of access into six categories: coverage and eligibility; barriers and cost; workforce and facilities; policy environment; patient context and equity; and treatment utilisation.


The report identifies six priorities for improving access nationwide:

  • Expand comprehensive coverage for the full range of evidence-based obesity treatments.

  • Reduce unnecessary restrictions and administrative barriers that delay or prevent care.

  • Strengthen the healthcare workforce and expand access to qualified obesity specialists and accredited treatment facilities.

  • Address geographic disparities through better referral networks, telehealth and travel support.

  • Measure meaningful access, including whether patients can obtain and continue treatment, rather than simply whether a benefit is listed as covered.

  • Eliminate weight bias and discrimination in healthcare policies and delivery.


To find out more about Obesity Treatment Access Scorecard, please click here

Comments


Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net

©2026 Dendrite Clinical Systems Ltd. All rights reserved.
No part of this website may be reproduced, stored in a retrieval system, transmitted in any form or by any other means without prior written permission from the Managing Editor. The views, comments and opinions expressed within are not necessarily those of Dendrite Clinical Systems or the Editorial Board. Bariatricnews.net is a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

bottom of page